Primecap Management CO Allogene Therapeutics, Inc. Transaction History
Primecap Management CO
- $132 Billion
- Q1 2024
A detailed history of Primecap Management CO transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Primecap Management CO holds 5,448,386 shares of ALLO stock, worth $13 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,448,386
Previous 5,281,886
3.15%
Holding current value
$13 Million
Previous $17 Million
43.65%
% of portfolio
0.02%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding ALLO
# of Institutions
162Shares Held
106MCall Options Held
97.5KPut Options Held
45.6K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$44.7 Million1.76% of portfolio
-
Black Rock Inc. New York, NY9.65MShares$23.1 Million0.0% of portfolio
-
State Street Corp Boston, MA9.18MShares$21.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.21MShares$19.6 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY5.18MShares$12.4 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $344M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...